References
- Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84–111. doi:10.1016/j.preteyeres.2016.02.002.
- Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606–614. doi:10.1016/j.ophtha.2006.07.040.
- Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2001;131:599–606.
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.
- Yang P, Ye Z, Du L, et al. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018;43:254–261. doi:10.1080/02713683.2017.1383444.
- Yuan W, Zhou C, Cao Q, et al. Longitudinal study of visual function in Vogt-Koyanagi-Harada disease using full-field electroretinography. Am J Ophthalmol. 2018;191:92–99. doi:10.1016/j.ajo.2018.04.013.
- Thorne JE, Jabs DA, Peters GB, et al. Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol. 2005;140:45–51. doi:10.1016/j.ajo.2005.01.035.
- Vianna RN, Ozdal PC, Filho JP, et al. Longterm follow-up of patients with multifocal choroiditis and panuveitis. Acta Ophthalmol Scand. 2004;82:748–753. doi:10.1111/j.1600-0420.2004.00343.x.
- Thorne JE, Wittenberg S, Jabs DA, et al. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity. Ophthalmology. 2006;113:2310–2316. doi:10.1016/j.ophtha.2006.05.067.
- Haen SP, Spaide RF. Fundus autofluorescence in multifocal choroiditis and panuveitis. Am J Ophthalmol. 2008;145:847–853. doi:10.1016/j.ajo.2008.01.008.
- Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58:203–232. doi:10.1016/j.survophthal.2012.08.008.
- Gerstenblith AT, Thorne JE, Sobrin L, et al. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology. 2007;114:1201–1204. doi:10.1016/j.ophtha.2006.10.047.
- Kedhar SR, Thorne JE, Wittenberg S, Dunn JP, Jabs DA. Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina. 2007;27:1174–1179. doi:10.1097/IAE.0b013e318068de72.
- Crawford CM, Igboeli O. A review of the inflammatory chorioretinopathies: the white dot syndromes. ISRN Inflamm. 2013;2013:783190. doi:10.1155/2013/783190.
- Rutzen AR, Ortega-Larrocea G, Frambach DA, Rao NA. Macular edema in chronic Vogt-Koyanagi-Harada syndrome. Retina. 1995;15:475–479.
- Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol. 2019;103:274–278. doi:10.1136/bjophthalmol-2017-311691.
- Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113:1446–1449. doi:10.1016/j.ophtha.2006.03.027.
- Perentes Y, Tran VT, Sickenberg M, et al. Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome. Ocul Immunol Inflamm. 2005;13:219–224. doi:10.1080/09273940490518883.
- Arevalo JF, Lasave AF, Gupta V, et al. Clinical outcomes of patients with Vogt-Koyanagi-Harada disease over 12 years at a tertiary center. Ocul Immunol Inflamm. 2016;24:521–529. doi:10.3109/09273948.2015.1025984.
- Wu K, Zhang X, Su Y, et al. Clinical Characteristics of inflammatory choroidal neovascularization in a Chinese population. Ocul Immunol Inflamm. 2016;24:261–267. doi:10.3109/09273948.2015.1015741.
- Roesel M, Ruttig A, Schumacher C, Heinz C, Heiligenhaus A. Risk factors for the development of macular edema in noninfectious uveitis. Eur J Ophthalmol. 2011;21:625–630.
- van Kooij B, Probst K, Fijnheer R, et al. Risk factors for cystoid macular oedema in patients with uveitis. Eye (Lond). 2008;22:256–260. doi:10.1038/sj.eye.6702595.